Further exploration of the pathways through which ROS influences mitophagy to alter the progression of ischemic cardiomyopathy has shown that inhibition of Parkin-mediated mitophagy leads to excessive mitochondrial ROS accumulation, promoting myocardial injury and heart failure [85]. The gene discussed is PRKN; the disease is ischemic cardiomyopathy.